Press release
Enzyme Immunoassay Market Research Reveals Path To $30.37 Billion By 2030
Enzyme Immunoassay Market
Projected Growth and Market Size of the Enzyme Immunoassay Market
The enzyme immunoassay market is anticipated to experience significant growth by 2030, reaching a valuation of $30.37 billion. This corresponds to a compound annual growth rate (CAGR) of 7.1% over the forecast period. This upward trend is largely fueled by advancements in fully automated EIA analyzers, the expanding field of personalized medicine and precision diagnostics, greater integration of laboratory information systems, increased use of software and data analytics tools, and heightened demand from academic and research institutions. Key market trends expected include broader adoption of automated EIA analyzers, rising applications in therapeutic drug monitoring, growth in multiplex testing and high-throughput assays, expansion in oncology and infectious disease testing, and a stronger focus on laboratory data integration and workflow optimization.
Download a free sample of the enzyme immunoassay market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Leading Companies Shaping the Enzyme Immunoassay Market
Several major organizations play pivotal roles in the enzyme immunoassay market, including F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton dic*kinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, and Calbiotech Inc. These companies contribute significantly to innovation and supply across various facets of the enzyme immunoassay industry.
Strategic Acquisition to Strengthen Market Position
In January 2025, Medix Biochemica, a Finnish company specializing in raw materials for in vitro diagnostics, acquired Germany-based CANDOR Bioscience GmbH for an undisclosed sum. This acquisition aims to enhance Medix Biochemica's global standing as a provider of raw materials by broadening its immunoassay portfolio. CANDOR Bioscience's expertise in producing high-performance blockers and assay optimization reagents is expected to improve assay performance and offer stronger support for diagnostic test development, particularly in enzyme immunoassays and ELISA.
View the full enzyme immunoassay market report:
https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Emerging Trends Highlighting Automation in Enzyme Immunoassay
Key players in the enzyme immunoassay market are focusing on launching innovative EIA solutions, particularly fully automated systems, to boost diagnostic precision, reduce human error, and improve laboratory workflows. Fully automated enzyme immunoassays perform the entire testing process independently, delivering faster, more reliable, and consistent results.
A notable example occurred in July 2024 when Fujirebio Holdings Inc., a Japanese in vitro diagnostics firm, introduced the fully automated Lumipulse G GFAP assay for research use only. This chemiluminescent enzyme immunoassay detects glial fibrillary acidic protein (GFAP) in plasma and serum via the LUMIPULSE G platform, producing results in just 35 minutes. GFAP serves as a biomarker for neurological conditions such as multiple sclerosis, Alzheimer's and Parkinson's diseases, stroke, and traumatic brain injury. This launch expands Fujirebio's neurodegenerative disease testing portfolio, which already includes NfL, pTau217, and sTREM2, supporting comprehensive neuro profiling on a single automated system.
Detailed Segment Breakdown of the Enzyme Immunoassay Market
The enzyme immunoassay market is categorized as follows:
1) Product Segmentation: Reagents and Kits, Analyzers or Instruments, Software and Services
2) Specimen Types: Blood, Saliva, Urine, Other Specimens
3) Applications: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) End-Use Markets: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, Other End-Uses
Further subdivisions include:
- Reagents and Kits: Antibodies, Antigens, Substrates, Buffers and Stabilizers
- Analyzers or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers and Incubators
- Software and Services: Data Analysis and Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration and Validation Services, Technical Support and User Training
This comprehensive segmentation helps to understand the diverse components and applications driving this market's growth.
Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enzyme Immunoassay Market Research Reveals Path To $30.37 Billion By 2030 here
News-ID: 4570527 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Enzyme
Enzyme Stabilizer Market Report 2024 - Enzyme Stabilizer Market Size And Growth
"The Business Research Company recently released a comprehensive report on the Global Enzyme Stabilizer Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Enzyme Replacement Therapy Market: Advancing Treatment for Inherited Enzyme Defi …
The Enzyme Replacement Therapy Market at a global level was worth USD 10.1 Billion in 2022 and is anticipated to expand to USD 20.6 Billion by 2032, experiencing a CAGR of 7.6% during the forecast period of 2023-2032.
The Enzyme Replacement Therapy (ERT) Market stands at the forefront of medical innovation, offering transformative treatment options for individuals with inherited enzyme deficiencies. Enzyme replacement therapy involves the infusion of artificial enzymes into…
Anti-Inflammatory Activity Enzyme and Protease Enzyme | Pearlzyme Inc
Pearlzyme Inc. focuses on boosting animal immune systems against infection and increasing milk lactation with anti-inflammatory activity enzymes. Also enzyme feed additives demonstrates a commitment to improving animal health and productivity. By developing innovative products, the company aims to provide effective solutions to its customers.
Pearlzyme Inc is committed to sustainable development and reducing environmental impact. As an environmentally conscious company, it recognizes the importance of minimizing its footprint and contributing…
Meat Tenderizing Agents Market 2018 Flourishes with International Prestigious Pl …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Meat Tenderizing Agents Market 2018 Flourishes with International Prestigious Pl …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Meat Tenderizing Agents Market Global Leader | Enzyme Bioscience Pvt. Ltd, AB En …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
